LEXICON PHARMACEUTICALS, INC. (LXRX) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $51.44M; Long-term Debt and Lease ObligationUSD (m); Secured DebtUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $49.68M; Long-term Debt and Lease ObligationUSD (m); Secured DebtUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $4.59M; Long-term Debt, Excluding Current MaturitiesUSD $49.41M; Long-term Debt and Lease ObligationUSD (m); Secured DebtUSD (m).
- 2025-09-30: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $56.51M; Long-term Debt and Lease ObligationUSD (m); Secured DebtUSD (m).
LEXICON PHARMACEUTICALS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt and Lease Obligation USD | Secured Debt USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Long-term Debt, Gross USD | Debt Instrument, Face Amount USD | Debt Instrument, Fair Value Disclosure USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Convertible, Conversion Ratio pure | Debt Instrument, Convertible, Conversion Price USD/shares | Debt Instrument, Convertible, If-converted Value in Excess of Principal USD | Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate pure | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $51.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $49.68M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $4.59M | $49.41M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $56.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $56.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $42.06M | $58.64M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $100.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $99.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $99.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $99.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $99.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $99.27M | (m) | (m) | $99.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 7.90% | (m) | (m) | (m) | 8.01% | $6.70M |
| 2023-06-30 | (m) | $98.77M | $5.48M | (m) | $98.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $7.20M |
| 2023-03-31 | (m) | $48.84M | $5.45M | (m) | $48.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $48.58M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $5.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | $48.60M | (m) | (m) | (m) | (m) | (m) | (m) | $-48.58M | (m) | (m) | 7.90% | (m) | (m) | (m) | 8.01% | (m) |
| 2022-09-30 | (m) | $23.78M | $5.44M | (m) | $23.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 7.90% | (m) | (m) | (m) | 8.01% | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 7.90% | (m) | (m) | (m) | 8.01% | (m) |
| 2022-06-30 | (m) | $23.63M | $1.00M | (m) | $23.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 7.90% | (m) | (m) | (m) | 8.01% | (m) |
| 2022-03-31 | (m) | $23.48M | $1.10M | (m) | $23.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $0.00 | $1.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) |
| 2021-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9.00% | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $11.69M | (m) | $1.48M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $11.90M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $11.68M | (m) | $1.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $12.10M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $11.66M | (m) | $1.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $12.60M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) |
| 2020-12-31 | $11.65M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $0.00 | $611.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $9.20M | 9.00% | (m) | 8.44 | (m) | (m) | (m) |
| 2020-09-30 | $8.69M | $11.63M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $15.40M | 9.00% | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $10.46M | $234.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $44.70M | 9.00% | (m) | (m) | (m) | (m) | $2.00M |
| 2020-03-31 | $10.73M | $234.49M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $55.20M | 9.00% | (m) | (m) | (m) | (m) | $2.20M |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $5.07M | (m) | (m) |
| 2019-12-31 | $11.01M | $234.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $1.10M | (m) | $248.63M | $11.13M | $87.50M | $150.00M | $0.00 | $0.00 | $0.00 | (m) | (m) | $64.80M | 9.00% | (m) | 8.44 | (m) | (m) | (m) |
| 2019-09-30 | $11.29M | $233.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $76.00M | 9.00% | (m) | (m) | (m) | (m) | $2.60M |
| 2019-06-30 | $1.11M | $243.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $95.60M | 9.00% | (m) | (m) | (m) | (m) | $2.80M |
| 2019-03-31 | $1.11M | $243.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $90.70M | 9.00% | (m) | (m) | (m) | (m) | $3.00M |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) |
| 2018-12-31 | $1.11M | $243.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | $249.91M | $1.28M | $11.13M | $87.50M | $150.00M | $0.00 | $0.00 | (m) | (m) | $97.50M | 9.00% | (m) | 8.44 | (m) | (m) | (m) |
| 2018-09-30 | $1.11M | $243.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $130.90M | 9.00% | (m) | (m) | (m) | (m) | $3.40M |
| 2018-06-30 | $12.90M | $232.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $145.90M | 9.00% | (m) | (m) | (m) | (m) | $3.70M |
| 2018-03-31 | $13.52M | $231.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $111.90M | 8.23% | (m) | (m) | (m) | (m) | $3.90M |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) |
| 2017-12-31 | $14.09M | $231.58M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | $251.59M | $14.09M | $0.00 | $0.00 | $87.50M | $150.00M | $0.00 | (m) | (m) | $127.30M | 9.00% | (m) | 8.44 | (m) | (m) | (m) |
| 2017-12-18 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $150.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $14.63M | $85.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $141.60M | 8.23% | (m) | 8.44 | (m) | (m) | (m) |
| 2017-06-30 | $15.16M | $85.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $165.50M | 8.23% | (m) | 8.44 | (m) | (m) | (m) |
| 2017-03-31 | $15.75M | $85.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $161.10M | 8.23% | (m) | 8.44 | (m) | (m) | (m) |
| 2016-12-31 | $16.28M | $85.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | $101.45M | $16.28M | $0.00 | $0.00 | $0.00 | $85.17M | $0.00 | (m) | (m) | $160.50M | 8.23% | (m) | 8.44 | (m) | (m) | (m) |
| 2016-09-30 | $16.79M | $85.04M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $197.70M | 8.23% | (m) | 8.44 | (m) | (m) | (m) |
| 2016-06-30 | $17.29M | $84.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $159.80M | 8.23% | (m) | 8.44 | (m) | (m) | (m) |
| 2016-03-31 | $2.02M | $100.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $144.70M | 8.23% | (m) | 8.44 | (m) | (m) | (m) |
| 2015-12-31 | $1.98M | $100.96M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | $105.81M | $2.02M | $16.29M | $0.00 | $0.00 | $0.00 | $87.50M | (m) | (m) | $154.20M | 8.23% | (m) | 8.44 | (m) | (m) | (m) |
| 2015-09-30 | $18.79M | $87.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $129.80M | 8.23% | (m) | 8.44 | (m) | (m) | (m) |
| 2015-06-30 | $19.25M | $87.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $100.70M | 8.23% | (m) | 8.44 | (m) | (m) | (m) |
| 2015-03-31 | $19.71M | $87.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $87.50M | 8.23% | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $20.17M | $87.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1.21 | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | $107.67M | $1.86M | $2.02M | $16.29M | $0.00 | $0.00 | $87.50M | (m) | (m) | $81.00M | 8.23% | (m) | (m) | (m) | (m) | (m) |
| 2014-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · 11845.53% | (m) | (m) | (m) | (m) |
| 2014-11-20 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.44 | (m) | (m) | (m) |
| 2014-09-30 | $20.61M | $0.00 | (m) | $20.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.23% | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $1.78M | $19.25M | (m) | $21.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.23% | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $1.75M | $19.71M | (m) | $21.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.23% | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $1.71M | $20.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | $21.88M | $1.71M | $1.86M | $2.02M | $16.29M | (m) | (m) | (m) | (m) | (m) | 8.23% | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $1.68M | $20.61M | (m) | $22.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.23% | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $22.68M | $0.00 | (m) | $22.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.23% | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $1.61M | $21.46M | (m) | $23.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.23% | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $1.57M | $21.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | $23.45M | $1.57M | $21.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.23% | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $1.54M | $22.28M | (m) | $23.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.23% | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $1.51M | $22.68M | (m) | $24.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.23% | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $1.48M | $23.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $1.44M | $23.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | $1.41M | $23.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $1.38M | $24.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $1.14M | $27.34M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |